186 related articles for article (PubMed ID: 10782667)
21. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.
Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F
Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and antiproliferative activity evaluation of fluorine-containing chalcone derivatives.
Burmaoglu S; Aktas Anil D; Gobek A; Kilic D; Yetkin D; Duran N; Algul O
J Biomol Struct Dyn; 2022 May; 40(8):3525-3550. PubMed ID: 33200677
[TBL] [Abstract][Full Text] [Related]
25. 1,2,3-Triazole tethered β-lactam-chalcone bifunctional hybrids: synthesis and anticancer evaluation.
Singh P; Raj R; Kumar V; Mahajan MP; Bedi PM; Kaur T; Saxena AK
Eur J Med Chem; 2012 Jan; 47(1):594-600. PubMed ID: 22071256
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.
Wang Y; Xue S; Li R; Zheng Z; Yi H; Li Z
Bioorg Med Chem; 2018 Jan; 26(1):8-16. PubMed ID: 29223717
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumorigenic chalcones.
Shibata S
Stem Cells; 1994 Jan; 12(1):44-52. PubMed ID: 8142919
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
Na Y; Nam JM
Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds.
El-Meligie S; Taher AT; Kamal AM; Youssef A
Eur J Med Chem; 2017 Jan; 126():52-60. PubMed ID: 27744186
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis and biological evaluation of diarylamines with antitumor activity].
Wang SB; Wang XF; Xie L
Yao Xue Xue Bao; 2013 Aug; 48(8):1273-80. PubMed ID: 24187835
[TBL] [Abstract][Full Text] [Related]
31. Bis-chalcone analogues as potent NO production inhibitors and as cytotoxic agents.
Vijaya Bhaskar Reddy M; Shen YC; Ohkoshi E; Bastow KF; Qian K; Lee KH; Wu TS
Eur J Med Chem; 2012 Jan; 47(1):97-103. PubMed ID: 22115618
[TBL] [Abstract][Full Text] [Related]
32. Novel carbapenem chalcone derivatives: synthesis, cytotoxicity and molecular docking studies.
Kommidi DR; Pagadala R; Rana S; Singh P; Shintre SA; Koorbanally NA; Jonnalagadda SB; Moodley B
Org Biomol Chem; 2015 Apr; 13(14):4344-50. PubMed ID: 25767041
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis.
Zhu M; Wang J; Xie J; Chen L; Wei X; Jiang X; Bao M; Qiu Y; Chen Q; Li W; Jiang C; Zhou X; Jiang L; Qiu P; Wu J
Eur J Med Chem; 2018 Sep; 157():1395-1405. PubMed ID: 30196062
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic activities of Mannich bases of chalcones and related compounds.
Dimmock JR; Kandepu NM; Hetherington M; Quail JW; Pugazhenthi U; Sudom AM; Chamankhah M; Rose P; Pass E; Allen TM; Halleran S; Szydlowski J; Mutus B; Tannous M; Manavathu EK; Myers TG; De Clercq E; Balzarini J
J Med Chem; 1998 Mar; 41(7):1014-26. PubMed ID: 9544201
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, dimerization, and biological activity of hexaoxygenated chalcones related to calythropsin and combretastatins.
Seguin E; Elomri A; Magiatis P; Skaltsounis AL; Chao LR; Tillequin F
Nat Prod Lett; 2002 Jun; 16(3):187-93. PubMed ID: 12049219
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
38. Total synthesis and bioactivity of unique flavone desmosdumotin B and its analogs.
Nakagawa-Goto K; Bastow KF; Wu JH; Tokuda H; Lee KH
Bioorg Med Chem Lett; 2005 Jun; 15(12):3016-9. PubMed ID: 15913998
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of bifendate-chalcone hybrids as a new class of potential P-glycoprotein inhibitors.
Gu X; Ren Z; Tang X; Peng H; Ma Y; Lai Y; Peng S; Zhang Y
Bioorg Med Chem; 2012 Apr; 20(8):2540-8. PubMed ID: 22429509
[TBL] [Abstract][Full Text] [Related]
40. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
